·
5 Min Read

Dec. 13, 2018: State Advocacy Update

Pennsylvania response to the opioid epidemic, AAP quality improvement course and more in AMA's latest state advocacy news.

Advocacy Update
Richard Deem, the AMA’s senior vice president for advocacy
·
4 Min Read

5 ways the midterms shook up the U.S. health care agenda for 2019

Prescription-drug pricing, gun violence and ACA-stabilization efforts are among the issues that could see new life next year.

Access to Care
·
2 Min Read

Vaping is an epidemic and the FDA must act, physicians say

FDA should ban flavoring agents and consider tight restrictions on marketing of e-cigarettes to people under 21.

Behavioral Health
·
3 Min Read

AMA statement on FDA plan to prevent youth access to flavored tobacco

The AMA applauds FDA’s announcement of its plan to make harmful tobacco products less accessible and less appealing to our nation’s youth.

Press Releases
·
5 Min Read

Nov. 15, 2018: State Advocacy Update

Medical societies urge New York to sign parity legislation, saving time and lives in Pennsylvania and more in the latest state advocacy news.

Advocacy Update
Two delegates consulting at 2018 AMA Interim Meeting
·
2 Min Read

AMA: Fix hospital eligibility criteria for drug-discount program

Outpatient charity care should determine 340B program eligibility as part of a revised formula for the federal program, physicians say.

Behavioral Health
·
3 Min Read

AMA expands anti-tobacco policies to further protect youth

The AMA adopted policies encouraging the FDA to prohibit the use of flavoring agents in tobacco products, including electronic nicotine delivery systems.

Press Releases
·
4 Min Read

AMA policy on in-person importation of prescription drugs from Canada

Physicians at the Interim Meeting of the AMA adopted policy supporting in-person importation of prescription drugs from licensed Canadian pharmacies.

Press Releases
Presenting at a panel
·
2 Min Read

AMA backs in-person import of Canadian Rx if safety is assured

Allowing the practice offers patients an option to lower patient out-of-pocket spending on prescription drugs, which addresses a barrier to medication adherence: unaffordability.

Behavioral Health